Caffeine Modulates Tau Phosphorylation and Affects Akt Signaling in Postmitotic Neurons

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Molecular Neuroscience

• Publication date

  2011-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12031-010-9444-8PMID 20838929
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The neuronal cell cycle as a mechanism of pathogenesis in Alzheimer's disease

  2009cited by this paper
• Caffeine Reverses Cognitive Impairment and Decreases Brain Amyloid-β Levels in Aged Alzheimer's Disease Mice

  2009cited by this paper
• Phosphorylation of tau at Ser214 mediates its interaction with 14‐3‐3 protein: implications for the mechanism of tau aggregation

  2009cited by this paper
• The PI3K-Akt-mTOR pathway regulates Aβ oligomer induced neuronal cell cycle events

  2009influential reference
• Interactions Between Glycogen Synthase Kinase 3β, Protein Kinase B, and Protein Phosphatase 2A in Tau Phosphorylation in Mouse N2a Neuroblastoma Cells

  2009cited by this paper
• Loss of neuronal cell cycle control as a mechanism of neurodegeneration in the Presenilin-1 Alzheimer's disease brain

  2008cited by this paper
• The enigmatic effects of caffeine in cell cycle and cancer.

  2007influential reference
• BRCA1 May Modulate Neuronal Cell Cycle Re-Entry in Alzheimer Disease

  2007influential reference
• Neuronal cell cycle re-entry mediates Alzheimer disease-type changes.

  2007cited by this paper
• Conditional Neuronal Simian Virus 40 T Antigen Expression Induces Alzheimer-Like Tau and Amyloid Pathology in Mice

  2007influential reference
• Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice.

  2007cited by this paper
• The neuroprotective effects of caffeine

  2007cited by this paper
• Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.

  2005cited by this paper
• Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology

  2005influential reference
• ReviewTwenty Years of the Alzheimer ’ s Disease Amyloid Hypothesis : A Genetic Perspective

  2005cited by this paper
• P3-216 Neuronal immunoreactivity for COX-2 and phosphorylation of PRB precede P38 MAPK activation and neurofibrillary changes in AD temporal cortex

  2004cited by this paper
• Adenosine A2A receptor facilitates calcium-dependent protein secretion through the activation of protein kinase A and phosphatidylinositol-3 kinase in PC12 cells.

  2004cited by this paper
• Cell cycle activation linked to neuronal cell death initiated by DNA damage.

  2004influential reference
• Neuronal COX-2 expression and phosphorylation of pRb precede p38 MAPK activation and neurofibrillary changes in AD temporal cortex.

  2004influential reference
• Akt/PKB kinase phosphorylates separately Thr212 and Ser214 of tau protein in vitro.

  2003cited by this paper
• Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells.

  2002cited by this paper
• Lack of Neurodegeneration in Transgenic Mice Overexpressing Mutant Amyloid Precursor Protein Is Associated with Increased Levels of Transthyretin and the Activation of Cell Survival Pathways

  2002cited by this paper
• Does caffeine intake protect from Alzheimer's disease?

  2002cited by this paper
• Abnormal Tau phosphorylation of the Alzheimer‐type also occurs during mitosis

  2002cited by this paper
• Rapid Tyrosine Phosphorylation of Neuronal Proteins Including Tau and Focal Adhesion Kinase in Response to Amyloid-β Peptide Exposure: Involvement of Src Family Protein Kinases

  2002cited by this paper
• Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

  2002cited by this paper
• Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK‐3β

  2002cited by this paper
• Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.

  1999cited by this paper
• Mitotic phosphorylation of tau protein in neuronal cell lines resembles phosphorylation in Alzheimer's disease.

  1998cited by this paper
• Lithium Reduces Tau Phosphorylation by Inhibition of Glycogen Synthase Kinase-3*

  1997cited by this paper
• Characterization of nerve growth factor-dependent herpes simplex virus latency in neurons in vitro

  1988cited by this paper

• Extracellular Vesicles and Purinergic Signaling in Alzheimer’s Disease—Joining Forces for Novel Therapeutic Approach

  2025cites this paper
• Novel Quinazoline Derivatives as Highly Effective A2A Adenosine Receptor Antagonists

  2024cites this paper
• Association of caffeine consumption with cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease: A BALTAZAR cohort study

  2024cites this paper
• From Cup to Cure: The Impact of Matcha Tea on Alzheimer’s Disease

  2024cites this paper
• Adenosine receptor signalling in Alzheimer’s disease

  2022cites this paper
• The Neuroprotective Effects of Moderate and Regular Caffeine Consumption in Alzheimer's Disease

  2021cites this paper
• The relevance of natural compounds in the Alzheimer´s Disease

  2018cites this paper
• Perinatal low-protein diet alters brainstem antioxidant metabolism in adult offspring

  2016cites this paper
• Antioxidant Activity of Caffeine: A Focus on Human Red Blood Cells and Correlations with Several Neurodegenerative Disorders

  2015cites this paper
• The Effects of Coffee Consumption on Cognition and Dementia Diseases

  2015cites this paper
• From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?

  2014cites this paper
• Interaction between glucocorticoid and adenosine A2A receptors in the hippocampus : implications for learning and memory

  2014cites this paper
• Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology.

  2014cites this paper
• Conséquences de l'invalidation génétique et pharmacologique des récepteurs adénosinergiques A2A dans un modèle de pathologie Tau. Relation avec les aspects neuro-inflammatoires

  2013cites this paper
• Adenosine Receptors and Alzheimer’s Disease

  2013cites this paper
• Cellular model of Alzheimer's disease--relevance to therapeutic testing.

  2012cites this paper